drugset / Trial / NCT05537584

SMART Trial to Predict Anhedonia Response to Antidepressant Treatment

NCT05537584

Phase 4 Completed 133 enrolled Mclean Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main goal of this research is to use behavioral, brain, and clinical data to determine which type of antidepressant might be optimal before people with depression start treatment.

Timeline

Start
2022-09-30
Primary completion
2025-08-26
Completion
2025-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Sertraline Small molecule